You are here
Award Data
The Award database is continually updated throughout the year. As a result, data for FY24 is not expected to be complete until March, 2025.
Download all SBIR.gov award data either with award abstracts (290MB)
or without award abstracts (65MB).
A data dictionary and additional information is located on the Data Resource Page. Files are refreshed monthly.
The SBIR.gov award data files now contain the required fields to calculate award timeliness for individual awards or for an agency or branch. Additional information on calculating award timeliness is available on the Data Resource Page.
-
Bayesian-Based Probabilistic Limit Cycle Oscillation Prediction of Aircraft with Stores
SBC: ZONA TECHNOLOGY INC Topic: AF18BT008The overall technical objective of the Phase II effort is to extend the Phase I developments and achieve a fully predictive Bayesian-based, data driven, probabilistic prediction tool of the F-16 limit cycle oscillation (LCO). This tool will rely on the available flight test data on some configurations to predict the LCO amplitude on different configurations within an uncertainty band that account ...
STTR Phase II 2020 Department of DefenseAir Force -
Space-Based Computational Imaging System
SBC: ALPHACORE INC Topic: AF19AT015New advances in onboard processing hardware, coupled with novel image sensor and camera design, have enabled the Air Force to consider the revolutionary benefits of computational imaging systems for space. Of particular interest to the Air Force are computational imaging systems that combine both optical and computational elements in ways that have the potential to outperform traditional (all-op ...
STTR Phase II 2020 Department of DefenseAir Force -
Portable Affordable Innovative and Smart Device-Coupled Electronic Fetal Monitoring System to Improve Rural Access to Obstetrics Services and Improve Outcomes in Rural Communities
SBC: Fetal Life, LLC Topic: 102Obstetricians measure fetal heartrate (FHR) and uterine contractions to evaluate fetal health during pregnancy and labor. This monitoring is performed to decrease the development of complications while minimizing the need for unnecessary obstetric interventions and is especially important for women with high-risk pregnancies. However, many women, especially in rural areas, do not have the time or ...
STTR Phase I 2020 Department of Health and Human ServicesNational Institutes of Health -
Extracellular NAMPT is a Novel Therapeutic Target in Chorioamnionitis-Related Prematurity (ChorP)
SBC: AQUALUNG THERAPEUTICS, CORP Topic: NICHDABSTRACT: Intrauterine infection and chorioamnionitis are common complications of pregnancy associated with significant maternal, perinatal, and long-term adverse outcomes. Adverse maternal outcomes include postpartum infections and sepsis while adverse infant outcomes include stillbirth, premature birth, neonatal sepsis, chronic lung disease and brain injury leading to cerebral palsy and other ne ...
STTR Phase I 2020 Department of Health and Human ServicesNational Institutes of Health -
Contamination resistant interconnection for reducing peritoneal dialysis- associated peritonitis
SBC: CEROVATIONS LLC Topic: 400Abstract Significance: Peritonitis remains a significant challenge in the management of end stage renal disease (ESRD) for patients on peritoneal dialysis (PD) and contributes significantly to morbidity and mortality. More than half of these infections result from bacteria originating on skin or mucous membranes, suggesting patient or caregiver contamination as the source of infections. Furthermor ...
STTR Phase I 2020 Department of Health and Human ServicesNational Institutes of Health -
A novel non-invasive method of aspiration detection in preterm infants.
SBC: NUBORN MEDICAL INC Topic: NICHDPROJECT SUMMARY/ABSTRACT Ten percent of the approximately four million infants born in the United States each year are born premature (andlt;37 weeks gestational age). Preterm birth prior to the maturation of critical neonatal body systems results in prolonged hospitalizations that impose an annual societal cost burden of $26 billion. Achievement of the ability to fully orally feed is often the la ...
STTR Phase I 2020 Department of Health and Human ServicesNational Institutes of Health -
Therapeutic targeting of Nox2 and Nox4 in Duchenne Muscular Dystrophy
SBC: Fibronox Topic: NHLBIABSTRACT: Duchenne muscular dystrophy (DMD) caused by a genetic mutation that prevents the production of dystrophin, a protein that muscles need to work properly. DMD patients exhibit progressive muscle weakness occurs in both skeletal and cardiac muscle. Cardiac fibrosis is ultimately the leading cause of their premature death. There is no cure for DMD, thus it remains an unmet medical need. Any ...
STTR Phase I 2020 Department of Health and Human ServicesNational Institutes of Health -
1 Micrometer Integrated Transmitter for Balanced Radio-Frequency-Over-Fiber Photonic Links
SBC: N.P. PHOTONICS, INC. Topic: N20BT030NP Photonics proposes to design and develop a compact and integrated radio frequency (RF) -to-optical transmitter at 1060 nm for balanced RF-over fiber photonic links by taking advantage of our mature single-frequency laser technology, multicore fiber fabrication technology, and substantial heterogeneous packaging experience and capability in fiber laser products. In this Phase I program, we will ...
STTR Phase I 2020 Department of DefenseNavy -
EpiZode: Noninvasive Seizure Screening in Preclinical Models of Epilepsy
SBC: SIGNAL SOLUTIONS LLC Topic: 100EpiZode: Noninvasive Seizure Screening in Preclinical Models of Epilepsy There is an urgent need for research into treatment options for epilepsy and other seizure disorders. Animal models are increasingly used to understand disease mechanisms and to screen promising therapeutic approaches. Animal epilepsy model use typically requires expensive and labor-intensive experimentation, with invasive EE ...
STTR Phase II 2020 Department of Health and Human ServicesNational Institutes of Health -
The MICELI Aggregometer: a Point-of-Care Platelet Function Analyzer
SBC: PLAKDX, LLC Topic: NHLBIPROJECT SUMMARY: While platelets are vital blood cells to maintain vascular integrity and foster tissue repair, unfortunately they may become “inappropriately” activated in a wide range of disease states. To reduce this activation risk anti- thrombotic drugs are routinely prescribed to an ever increasing variety of patients, in fact being leading agents prescribed by physicians today. While th ...
STTR Phase I 2020 Department of Health and Human ServicesNational Institutes of Health